← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

▼ SELL

$ Value

$872

Shares

765

Price

$1

Filed

Nov 6

Insider

Name

Prior Stephen David

Title

Chief Strategy Officer

CIK

0002042268

Roles

Officer

Transaction Details

Transaction Date

2025-11-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

65,548

Footnotes

Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on November 4, 2025. | Includes, in accordance with the original terms, (a) 10,125 RSUs which shall vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 and (b) 12,031 RSUs which shall vest on January 1, 2026, in each case, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date. | Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on September 30, 2025.

Filing Info

Accession No.

0001193125-25-270252

Form Type

4

Issuer CIK

0001880438

Prior Stephen David's History

Date Ticker Type Value
2026-01-06 ANTX $3K
2026-01-05 ANTX $4K
2025-11-04 ANTX $872

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03